The vitamin K2 market was valued at USD 98.77 billion in 2025 and is projected to reach USD 102.98 billion in 2026 and USD 145.62 billion by 2034, expanding at a CAGR of 4.4% during the forecast period 2026–2034. Growing awareness of cardiovascular health, advances in delivery technology, and wider regulatory acceptance are broadening applications beyond traditional supplements. Companies such as Kappa Bioscience, NattoPharma, DSM Nutritional Products, NOW Foods, and Life Extension compete on formulation quality and sourcing.

Cardiovascular Applications Extend the Vitamin K2 Market

Vitamin K2 activates proteins that direct calcium to bones and away from the arteries, supporting cardiovascular health alongside bone density. K2, especially MK-7, is being studied as a clinical adjunct for reducing arterial stiffness and vascular calcification, particularly in high-risk groups such as chronic kidney disease and dialysis patients. Nutraceutical products increasingly use K2 in formulas aimed at arterial flexibility, and the nutraceutical segment is registering the highest growth among applications, driven by preventive health preferences and rising demand for dietary supplements. Consumer focus on bone and cardiovascular health is also listed as a key trend driving vitamin K2 supplement demand.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/vitamin-k2-market

Capsules and Tablets Lead Form Factors

By form, the market is segmented into capsules and tablets, powder, and oil. Capsules and tablets hold the largest share because of convenience, accurate dosage, ease of consumption, and long shelf life, making them the most common format for retail and online distribution. Powder is registering the highest growth in smoothies, energy bars, and fortified beverages, where it offers easier formulation and higher concentrations per serving. Oil, the smallest segment, is growing steadily in nutraceuticals and personal care, where K2's fat-soluble properties enhance absorption.

Fermented Foods and Regulatory Validation

Fermented foods produced with specific bacteria, such as natto, are recognized as rich natural sources of vitamin K2 and serve as models for industrial fermentation-based production. Vitamin K2 also occurs in certain cheeses, and dairy fortification is being explored to improve dietary intake. EFSA and FDA have issued scientific opinions and GRAS responses on the safety of MK-7 added for nutritional purposes, and regulators are assessing MK-7 as a nutritive substance in fortified foods for special medical purposes. In Asia Pacific, a long-standing tradition of consuming fermented foods such as natto supports regional demand.

Microencapsulation and Combination Formulations

To improve stability and bioavailability, manufacturers are adopting technologies such as microencapsulation, particularly for MK-7, in supplements and fortified foods. This sits alongside a wider shift toward combination products. Pharmaceutical and over-the-counter products increasingly pair vitamin D3 with K2 in vitamin D3 and K2 formulations that synergistically support calcium metabolism for skeletal and cardiovascular benefits. K2 is also used as an adjunct to vitamin D and calcium in osteoporosis management, with evidence for maintaining bone mineral density and reducing vertebral fractures. Beyond vitamin D3 and K2 formulations, emerging blends combine K2 with omega-3 fatty acids, magnesium, and other micronutrients.

Regional and Competitive Outlook

North America held the largest share in 2025, supported by strong consumer awareness and established pharmaceutical and nutraceutical industries, while Asia Pacific is growing rapidly on rising health awareness and middle-class incomes. Competitive strategies center on product innovation, strategic partnerships, and regional expansion, alongside stringent quality and regulatory standards in Europe and North America.

In May 2023, NattoPharma expanded production capacity to meet rising global MK-7 demand, and in June 2022 Kappa Bioscience partnered with Balchem to incorporate its vitamin K2 into fortified dairy products. Other participants include Gnosis by Lesaffre, Zhejiang Medicine Co., Ltd., Sports Research Corporation, MaryRuth Organics, Herbalife Nutrition, and Nature's Way. Partnerships between key players and research institutions are enabling clinically backed products, and companies are launching new formulations that enhance bioavailability. Growth in e-commerce and direct-to-consumer sales is pushing companies to prioritize online channels.

More Trending Latest Reports By Polaris Market Research:

used-cooking-oil-uco-market

craft-soda-market

digital-transformation-market

top-automotive-engineering-services-companies

direct-to-consumer-testing-market

silicone-market

inside-the-diagnostics-world-top-5-virus-testing-kit-manufacturers

cast-polypropylene-films-market

product-information-management-market